Search - tctmd.com

Displaying 521 - 540 of 822

Sort: Relevancy | Date

News Daily News

Bailout DES Effective in CLI Patients with Below-the-Knee Lesions

April 19, 2013

Presentation Fellows 2013

Femoral vs. Radial: A Critical Appraisal of the Evidence

Presenter: Jennifer Tremmel

April 15, 2013

Presentation Fellows 2013

Femoral Vascular Access and Closure (Manual and Device Based): Step by Step

Presenter: Zoltan Turi

April 15, 2013

News Daily News

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

April 12, 2013

News Daily News

Se reportó infección post-TAVR en 1 de cada 5 pacientes, pero no asociada a la mortalidad

Yael L. Maxwell

April 12, 2013

News Daily News

Resultado de 2 Años del Zilver PTX Publicados: Seguridad y Eficacia Superiores frente a Angioplastia Sostenida

April 12, 2013

News Daily News

Primed Mesenchymal Stem Cells May Improve Heart Function

Caitlin E. Cox

April 12, 2013

News Daily News

Post-TAVR Infection Reported in 1 of 5 Patients But Not Linked with Mortality

Yael L. Maxwell

April 12, 2013

News Daily News

Las Células Madre Mesenquimales Cebadas podrían Mejorar la Función Cardíaca

Caitlin E. Cox

April 12, 2013

News Industry News

Medtronic Receives ‘CE’ Mark for Sentrant Introducer Sheath, Complementing Market-Leading Aortic Stent Grafts

April 04, 2013

News Daily News

Un Estudio Resalta las Diferencias de Género en el Riesgo Hemorrágico tras una PCI

L.A. McKeown

March 25, 2013

News Daily News

Study Highlights Gender Differences in Bleeding Risk After PCI

L.A. McKeown

March 25, 2013

News Daily News

Sedation Plus Analgesia Improves Transradial PCI by Decreasing Spasm

Jason Kahn

March 25, 2013

News Daily News

Sedación + Analgesia Mejoran la PCI Transradial Reduciendo los Espasmos

Jason Kahn

March 25, 2013

News Daily News

Panel de cierre de la FDA vota a favor del MitraClip para pacientes con RM que no tienen otras opciones

March 25, 2013

News Daily News

Close FDA Panel Vote Favors MitraClip for MR Patients with No Other Options

March 25, 2013

News Daily News

Same-Day Discharge After Elective PCI Safe, Preferred by Most Patients

March 20, 2013

News Industry News

FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery

March 20, 2013

News Industry News

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

March 11, 2013

News Industry News

Abbott's Minimally Invasive MitraClip® System for Mitral Regurgitation Demonstrates Positive Clinical and Quality- of-Life Results for Patients Too High Risk for Surgery

March 09, 2013

Advertisement

Bailout DES Effective in CLI Patients with Below-the-Knee Lesions

Femoral vs. Radial: A Critical Appraisal of the Evidence

Femoral Vascular Access and Closure (Manual and Device Based): Step by Step

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

Se reportó infección post-TAVR en 1 de cada 5 pacientes, pero no asociada a la mortalidad

Resultado de 2 Años del Zilver PTX Publicados: Seguridad y Eficacia Superiores frente a Angioplastia Sostenida

Primed Mesenchymal Stem Cells May Improve Heart Function

Post-TAVR Infection Reported in 1 of 5 Patients But Not Linked with Mortality

Las Células Madre Mesenquimales Cebadas podrían Mejorar la Función Cardíaca

Medtronic Receives ‘CE’ Mark for Sentrant Introducer Sheath, Complementing Market-Leading Aortic Stent Grafts

Un Estudio Resalta las Diferencias de Género en el Riesgo Hemorrágico tras una PCI

Study Highlights Gender Differences in Bleeding Risk After PCI

Sedation Plus Analgesia Improves Transradial PCI by Decreasing Spasm

Sedación + Analgesia Mejoran la PCI Transradial Reduciendo los Espasmos

Panel de cierre de la FDA vota a favor del MitraClip para pacientes con RM que no tienen otras opciones

Close FDA Panel Vote Favors MitraClip for MR Patients with No Other Options

Same-Day Discharge After Elective PCI Safe, Preferred by Most Patients

FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

Abbott's Minimally Invasive MitraClip® System for Mitral Regurgitation Demonstrates Positive Clinical and Quality- of-Life Results for Patients Too High Risk for Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content